Posterior subependymal germinal matrix hemorrhage as a mild form of hemorrhage in extremely preterm infants: neurodevelopmental outcomes at corrected ages of 18-24 months
Open Access
- 1 January 2025
- journal article
- research article
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 44 (1) , 48-61
Abstract
Purpose: This study aimed to explore the effects of both the presence and size of posterior subependymal germinal matrix hemorrhage (PS-GMH), considered a mild form of hemorrhage, on the neurodevelopmental outcomes of extremely preterm infants.Methods: A retrospective analysis was conducted on 221 extremely preterm infants, assessing their initial and term-equivalent age (TEA) cranial ultrasound (cUS) examinations from 2016 to 2021. Infants were classified based on the presence and size (small/large) of PS-GMH. Neurodevelopmental outcomes at corrected ages of 18-24 months were analyzed in 135 infants.Results: PS-GMH was identified in 86.9% (192/221) of the infants, with 13.5% (26/192) exhibiting large PS-GMH. Among the 135 infants who were followed up, those with PS-GMH were found to have younger gestational ages (P<0.001) and a higher incidence of maternal chorioamnionitis (P=0.016) than those without PS-GMH. Significant differences were observed in the incidence of grade II intraventricular hemorrhage (IVH) on initial cUS (P=0.003) and ventriculomegaly at TEA cUS (P=0.026) across the groups with no PS-GMH, small PS-GMH, and large PS-GMH. The large PS-GMH group exhibited a higher occurrence of grade II IVH than the small PS-GMH group (P=0.006). However, ventriculomegaly incidence did not significantly vary with PS-GMH status. Neurodevelopmental outcomes were also not significantly different across PS-GMH statuses. The adjusted odds ratios for any neurodevelopmental impairment, compared to the no PS-GMH group, were 1.70 (95% confidence interval [CI], 0.40 to 7.26; P=0.471) for all PS-GMH, 1.61 (95% CI, 0.37 to 6.93; P=0.526) for small PS-GMH, and 3.84 (95% CI, 0.62 to 24.00; P=0.150) for large PS-GMH.Conclusion: PS-GMH was frequently observed in extremely preterm infants; however, it did not independently predict adverse neurodevelopmental outcomes.Keywords
This publication has 32 references indexed in Scilit:
- Ganglionic eminence: volumetric assessment of transient brain structure utilizing fetal magnetic resonance imagingUltrasound in Obstetrics & Gynecology, 2023
- Normal and abnormal appearance of fetal ganglionic eminence on second‐trimester three‐dimensional ultrasoundUltrasound in Obstetrics & Gynecology, 2023
- Normal variant residual germinal matrix in extremely premature infants: radiographic features and imaging pitfallsJournal of Ultrasound, 2022
- Characterization of germinal matrix hemorrhage in extremely premature infants: recognition of posterior location and diagnostic pitfallsPediatric Radiology, 2021
- Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose-Escalation Clinical TrialStem Cells Translational Medicine, 2018
- Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular HemorrhageJAMA Pediatrics, 2018
- Expanding the spectrum of human ganglionic eminence region anomalies on fetal magnetic resonance imagingNeuroradiology, 2015
- Are Outcomes of Extremely Preterm Infants Improving? Impact of Bayley Assessment on OutcomesThe Journal of Pediatrics, 2012
- Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?Pediatric Nephrology, 2009
- Sequence of oligodendrocyte development in the human fetal telencephalonGlia, 2004